A clinical trial for Ebola treatments targeting the current outbreak in the Democratic Republic of Congo has commenced, enrolling its first patient, WHO announced.

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died